Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry Haematologica Myelodysplastic Syndromes (MDS)
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report Haematologica Aplastic Anemia
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia Haematologica Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry Haematologica Myelodysplastic Syndromes (MDS)
Germline variants in acquired aplastic anemia: current knowledge and future perspectives Haematologica Aplastic Anemia
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Haematologica Aplastic Anemia
Immunosuppression and Growth Factors for Severe Aplastic Anemia: New Data for Old Questions Haematologica Aplastic Anemia
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag Haematologica Aplastic Anemia
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.

We Recommend

For Research